Telehealth allows patients to become influential consumers—and fight against excess regulation

Telehealth has allowed patients to become more involved in their own care. It has also made them more influential consumers of healthcare. But such disruptions in medicine often face difficult regulatory hurdles.

Citing a study by the Employer Benefits Research Institute, the story claims nearly all large employers (96 percent) plan to offer telemedicine, thanks in part to growing consumer demand. Although regulatory barriers remain, legislation expanding telehealth under Medicare is being proposed to allow patients to use the services.

“It’s a peace of mind issue. We want employees to know that they and their families are going to get access to high quality care regardless of where they live,” said Annette Guarisco Fildes, president and CEO of the ERISA Industry Council, the key advocacy arm for employer benefits policy in Washington, D.C. “Telemedicine is particularly good for identifying health issues earlier and avoiding complications later.”

Read the full story below:

""
Cara Livernois, News Writer

Cara joined TriMed Media in 2016 and is currently a Senior Writer for Clinical Innovation & Technology. Originating from Detroit, Michigan, she holds a Bachelors in Health Communications from Grand Valley State University.

Around the web

Given the precarious excitement of the moment—or is it exciting precarity?—policymakers and healthcare leaders must set directives guiding not only what to do with AI but also when to do it. 

The final list also included diabetes drugs sold by Boehringer Ingelheim and Merck. The first round of drug price negotiations reduced the Medicare prices for 10 popular drugs by up to 79%. 

HHS has thought through the ways AI can and should become an integral part of healthcare, human services and public health. Last Friday—possibly just days ahead of seating a new secretary—the agency released a detailed plan for getting there from here.